Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M de Boer

Showing results (501-510 of 719) with videos related to

Pageof 72
Sort By:
Genes and Immunity|July 3, 2015
Nonallelic homologous recombination of the FCGR2/3 locus results in copy number variation and novel chimeric FCGR2 genes with aberrant functional expressionS Q Nagelkerke, C E Tacke, W B Breunis, et al.
Brain : a Journal of Neurology|May 5, 2022
Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology studyEleonora M Vromen, Sterre C M de Boer, Charlotte E Teunissen, et al.
BMC Cancer|November 13, 2015
Return-to-work intervention for cancer survivors: budget impact and allocation of costs and returns in the Netherlands and six major EU-countriesJanne C Mewes, Lotte M G Steuten, Iris F Groeneveld, et al.
European Urology Focus|April 27, 2019
Effectiveness of Preoperative Depilation of the Urethral Donor Site for Phalloplasty: Neourethral Hair Growth and its Effects on VoidingGarry L S Pigot, Saloua Belboukhaddaoui, Mark Bram Bouman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancerA Planting, S Kho, M van der Burg, et al.
Psycho-Oncology|July 29, 2017
Perceived employer-related barriers and facilitators for work participation of cancer survivors: A systematic review of employers' and survivors' perspectivesM A Greidanus, A G E M de Boer, A E de Rijk, et al.
Epilepsy & Behavior : E&B|July 29, 2009
Changes in knowledge, attitude, and practice of people with epilepsy and their families after an intervention in rural ChinaWenzhi Wang, Donghai Zhao, Jianzhong Wu, et al.
Optics Express|July 1, 2014
Protein detection on biotin-derivatized polyallylamine by optical microring resonatorsDaniela Ullien, Peter J Harmsma, Shahina M C Abdulla, et al.
British Journal of Cancer|March 1, 1996
Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administrationC J Gerrits, G J Creemers, J H Schellens, et al.
American Heart Journal|March 12, 2011
High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaborationSanneke P M de Boer, Elizabeth H Barnes, Cynthia M Westerhout, et al.
Pageof 72

Showing results (501-510 of 719) with videos related to

Sort By:
Pageof 72
Genes and Immunity|July 3, 2015
Nonallelic homologous recombination of the FCGR2/3 locus results in copy number variation and novel chimeric FCGR2 genes with aberrant functional expressionS Q Nagelkerke, C E Tacke, W B Breunis, et al.
Brain : a Journal of Neurology|May 5, 2022
Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology studyEleonora M Vromen, Sterre C M de Boer, Charlotte E Teunissen, et al.
BMC Cancer|November 13, 2015
Return-to-work intervention for cancer survivors: budget impact and allocation of costs and returns in the Netherlands and six major EU-countriesJanne C Mewes, Lotte M G Steuten, Iris F Groeneveld, et al.
European Urology Focus|April 27, 2019
Effectiveness of Preoperative Depilation of the Urethral Donor Site for Phalloplasty: Neourethral Hair Growth and its Effects on VoidingGarry L S Pigot, Saloua Belboukhaddaoui, Mark Bram Bouman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancerA Planting, S Kho, M van der Burg, et al.
Psycho-Oncology|July 29, 2017
Perceived employer-related barriers and facilitators for work participation of cancer survivors: A systematic review of employers' and survivors' perspectivesM A Greidanus, A G E M de Boer, A E de Rijk, et al.
Epilepsy & Behavior : E&B|July 29, 2009
Changes in knowledge, attitude, and practice of people with epilepsy and their families after an intervention in rural ChinaWenzhi Wang, Donghai Zhao, Jianzhong Wu, et al.
Optics Express|July 1, 2014
Protein detection on biotin-derivatized polyallylamine by optical microring resonatorsDaniela Ullien, Peter J Harmsma, Shahina M C Abdulla, et al.
British Journal of Cancer|March 1, 1996
Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administrationC J Gerrits, G J Creemers, J H Schellens, et al.
American Heart Journal|March 12, 2011
High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaborationSanneke P M de Boer, Elizabeth H Barnes, Cynthia M Westerhout, et al.
Pageof 72